AstraZeneca PLC (AZNl)

BATS Europe
Currency in GBP
11,998.0
+114.0(+0.96%)
Closed
AZNl Scorecard
Full Analysis
Trading at a high earnings multiple
Fair Value
Day's Range
11,854.012,016.0
52 wk Range
9,670.013,338.0
Key Statistics
Edit
Bid/Ask
11,994.00 / 11,994.00
Prev. Close
11,884
Open
11,862
Day's Range
11,854-12,016
52 wk Range
9,670-13,338
Volume
252.73K
Average Volume (3m)
252.94K
1-Year Change
16.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZNl Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

AstraZeneca PLC Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Employees
94300

Compare AZNl to Peers and Sector

Metrics to compare
AZNl
Peers
Sector
Relationship
P/E Ratio
34.2x23.6x−0.5x
PEG Ratio
1.890.060.00
Price/Book
5.9x3.1x2.6x
Price / LTM Sales
4.4x2.5x3.0x
Upside (Analyst Target)
-39.7%56.6%
Fair Value Upside
Unlock31.0%10.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.54
Dividend Yield
1.95%
Industry Median 1.27%
Annualized payout
233.60
Paid unevenly
5-Years Growth
+2.06%
Growth Streak

Earnings

Latest Release
Feb 06, 2025
EPS / Forecast
2.09 / 2.13
Revenue / Forecast
14.89B / 14.15B
EPS Revisions
Last 90 days

People Also Watch

655.70
ASML
+2.07%
605.10
LVMH
+0.02%
1,511.00
GSK
+0.80%
530.2
NOVOb
+0.99%
1,657.00
BAES
+4.18%

FAQ

What Is the AstraZeneca (AZNl) Stock Price Today?

The AstraZeneca stock price today is 11,998.00

What Stock Exchange Does AstraZeneca Trade On?

AstraZeneca is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for AstraZeneca?

The stock symbol for AstraZeneca is "AZNl."

Does AstraZeneca Pay Dividends? What’s The Current Dividend Yield?

The AstraZeneca PLC dividend yield is 2.05%.

What Is the AstraZeneca Market Cap?

As of today, AstraZeneca market cap is 185.98B.

What is AstraZeneca Earnings Per Share?

The AstraZeneca EPS is 4.54.

What Is the Next AstraZeneca Earnings Date?

AstraZeneca will release its next earnings report on Apr 28, 2025.

From a Technical Analysis Perspective, Is AZNl a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.